BJ
CORT icon

BlackRock Japan’s Corcept Therapeutics CORT Stock Holding History

BlackRock Japan’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$49K Buy
6,751
+3,005
+80% +$23.5K ﹤0.01% 987
2016
Q3 		$24K Buy
3,746
+2,472
+194% +$14.4K ﹤0.01% 1095
2016
Q2 		$7K Sell
1,274
-243
-16% -$1.26K ﹤0.01% 1308
2016
Q1 		$7K Hold
1,517
– – ﹤0.01% 1325
2015
Q4 		$8K Buy
+1,517
New +$6.84K ﹤0.01% 1288

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock Japan's CORT Position: Q4 2016 in Review

BlackRock Japan increased its Corcept Therapeutics (CORT) stake by 80% in Q4 2016, buying an estimated $23.5K and bringing the position to 6,751 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #987.

BlackRock Japan first reported a position in CORT in Q4 2015 and has held it in 5 quarters since. 135 funds tracked by Wall St. Rank hold CORT as of Q4 2016.

  • BlackRock Japan held 6,751 shares of Corcept Therapeutics worth $49K as of Q4 2016.
  • BlackRock Japan bought 3,005 Corcept Therapeutics shares in Q4 2016, an estimated $23.5K.
  • Corcept Therapeutics made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #987 holding.
  • BlackRock Japan first reported a position in Corcept Therapeutics in Q4 2015 and has held it in 5 quarters since.
  • 135 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.